An interventional study of PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml in Premature Ovarian Failure, sponsored by Tanta University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2023-02-17.
Sponsored by Tanta University · Not applicable, Interventional, and Treatment
All encountered cases with POI will be assessed and examined then investigated. Eligible cases will be included in the study
Patients will be subjected to injection of autologous PRP inside the ovary about 0.5-1 mml by laparoscopy
2,553 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's enrollment of 16 is below the median of 84 across 1,688 interventional studies indexed under Premature Birth.
Browse Premature Birth studies →Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
injection of PRP inside ovary by the assistance of laparoscopy
Procedure: PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml
intraovarian injection of 2 mml of PRP by laparoscopic guide
Resumption of ovarian hormonal function
Measurement of Estradiol level on Day 3 of cycle
Time frame: 3-6 months
Resumption of ovarian folliclugenesis
Assessment of the presence of oocytes by trans vaginal ultrasound on day 3
Time frame: 3-6 months
Resumption of menstruation
Occurrence of Menstruation after secondary amenrorrhea by questionnaire
Time frame: 3-6 months
Fertility potential
Potential to get pregnant after ICSI procedure
Time frame: 3-6 months
Plan to share: Undecided — we will decide later
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tanta University